J. Mel Sorensen
2018
In 2018, J. Mel Sorensen earned a total compensation of $521.6K as President and Chief Executive Officer at Galera Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $135,236 |
|---|---|
| Salary | $386,388 |
| Total | $521,624 |
Sorensen received $386.4K in salary, accounting for 74% of the total pay in 2018.
Sorensen also received $135.2K in non-equity incentive plan.
Rankings
In 2018, J. Mel Sorensen's compensation ranked 11,734th out of 14,244 executives tracked by ExecPay. In other words, Sorensen earned more than 17.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,734 out of 14,244 | 18th |
Division Manufacturing | 4,738 out of 5,765 | 18th |
Major group Chemicals And Allied Products | 1,797 out of 2,128 | 16th |
Industry group Drugs | 1,531 out of 1,817 | 16th |
Industry Pharmaceutical Preparations | 1,173 out of 1,391 | 16th |
Source: SEC filing on April 27, 2020.
Sorensen's colleagues
We found one more compensation record of an executive who worked with J. Mel Sorensen at Galera Therapeutics in 2018.
2018
Robert Beardsley
Galera Therapeutics
Chief Operating Officer
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
January 24, 2025
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020